A pioneering collaboration between Omnigene Medical Technologies Ltd and the University of Malta is developing a liquid biopsy platform that could transform how cancer is monitored. Called M3Profiler, the technology analyses tumour-derived exosomes – tiny vesicles released into the bloodstream by cancer cells – to generate detailed molecular profiles from just a small blood sample.
A kick-off meeting, organised by Xjenza Malta on 28 July 2026, marked the launch of five new research and innovation (R&I) projects that foster greater collaboration between Malta-based researchers and partners in Türkiye. The projects, awarded funding under the fifth Xjenza Malta–TÜBİTAK Joint Call for Research and Innovation R&I Proposals (2025), cover a range of research areas, including aviation, health, water management, and farming systems.
Have you ever scrolled past a viral claim online and thought, ‘That sounds true’? Maybe it was a headline about a miracle cure or a diet hack. Or noticed how quickly new ideas spread online – sometimes before anyone has checked if they’re real? From scientific labs to TikTok feeds, we’re constantly asked to decide: What is true? And more often than not, the answer lies in one underappreciated scientific principle – reproducibility.
Most of us move through life with a quiet certainty that being alive is self-evident. We grow, think, love, worry, plan. We distinguish instinctively between what lives and what does not. A person is alive; a stone is not. A dog is alive; a machine is not. The line feels obvious, until someone asks us to explain it.
